{
  "run_date_utc": "2026-01-08",
  "pipeline_source": {
    "url": "https://s203.q4cdn.com/636242992/files/doc_financials/2025/q3/JNJ-Pipeline-3Q25.pdf",
    "stored_pdf": "sources/jnj/2026-01-08.pdf",
    "sha256": "7be7a71814f547e8772f826b14552f40244c9d6a9dd0548d8b79a85c3f1a9e04"
  },
  "diff": {
    "added": [],
    "removed": [],
    "phase_changes": []
  },
  "ctgov": {
    "enabled": true,
    "queried_assets": [
      "AKEEGA (niraparib/abiraterone)",
      "DARZALEX (daratumumab)",
      "IMBRUVICA (ibrutinib)",
      "INLEXZO (gemcitabine intravesical system)",
      "RYBREVANT (amivantamab)",
      "Bleximenib",
      "CARVYKTI (Ciltacabtagene autoleucel)",
      "ERLEADA (apalutamide)",
      "JNJ-1900 (NBTXR3)",
      "pasritamig",
      "TALVEY + TECVAYLI",
      "TALVEY (talquetamab)",
      "TAR-210 (RIS/erdafitinib)",
      "TECVAYLI (teclistamab)",
      "JNJ-0683 (ARX788)",
      "JNJ-0387",
      "JNJ-0631 (ARX305)",
      "JNJ-1493",
      "JNJ-2638",
      "JNJ-2761",
      "JNJ-3413",
      "JNJ-4496",
      "JNJ-4680"
    ],
    "queries_executed": 23,
    "programs_total": 101,
    "programs_with_matches": 25,
    "phase_mismatches": 0,
    "sources_path": "sources/jnj/ctgov/2026-01-08",
    "api_base": "https://clinicaltrials.gov/api/v2"
  },
  "sec_edgar": {
    "summary": {
      "enabled": true,
      "since_date": "2026-01-08",
      "filings_considered": 0,
      "filings_with_events": 0,
      "sources_path": "sources/jnj/sec/2026-01-08"
    },
    "filing_events": []
  },
  "final_brief": {
    "headline": "No pipeline update detected",
    "executive_summary": "The pipeline deck appears unchanged versus the last valid snapshot and no pipeline-relevant EDGAR signals were extracted in this run. See corroboration sections for ClinicalTrials.gov and filing coverage.",
    "top_changes": [],
    "watchlist": [
      "Monitor ClinicalTrials.gov for phase/status updates on priority assets.",
      "Monitor new SEC filings and earnings commentary for reprioritization or portfolio actions."
    ]
  }
}